Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Maternal vaccination timing shapes the composition and maturation of antibody clonotypes transferred to the newborn.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus Vaccine.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines.
Journal: bioRxiv : the preprint server for biology
Published: April 29, 2026
Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 27, 2026
A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.
A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.
Journal: Open forum infectious diseases
Published: March 19, 2026
Characterization of elite controllers with an undetectable intact HIV DNA reservoir.
Journal: The Journal of clinical investigation
Published: February 17, 2026
Safety, Immunovirologic, and Central Nervous System Effects of PD-1 Inhibition in People With HIV Without Malignancy.
Journal: The Journal of infectious diseases
Published: December 11, 2025
HIV-1 antibody-mediated neutralization via a dual-glycan clamp.
Journal: Cell reports
Published: December 05, 2025
Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine.
Journal: Science translational medicine
Published: November 12, 2025
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing.
Journal: iScience
Published: June 13, 2025
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in mice.
Journal: Science translational medicine
Published: April 30, 2025
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.
Journal: Nature communications
Published: December 05, 2024
Last Updated: 09/26/2026